top of page
Strategists and Implementers
for growing companies globally
Recent Postings
MedNews: Spectral AI (Nasdaq: MDAI) raises about $5 Million to strengthen its finances for an FDA Pathway
Spectral AI is a predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound decisions in
Nov 19, 20242 min read
MedNews: Triveni Bio raises $115 million to develop therapeutics addressing immunological and inflammatory disorders
Using a genetics-informed, precision medicine approach, the company seeks to establish proof-of-concept early in drug development
Oct 3, 20242 min read
MedNews: Retension Pharmaceuticals raises $10.4 million to fund clinical trials for patients suffering from resistant and uncontrolled hypertension
Retension Pharmaceuticals, Inc. is a clinical-stage biotechnology company developing RTN-001 as a therapy for patients with hypertension.
Aug 22, 20243 min read
MedNews: AI-enabled biotechnology company ReviR Therapeutics raises $30 million to advance oral genetic medicines for multiple CNS disorders
ReviR Therapeutics is a biopharmaceutical company focused on the development of RNA-targeting small molecule therapies
Jul 27, 20245 min read
ReShape Lifesciences, a weight loss and metabolic health-solutions company to merge with clinical stage specialty pharmaceutical company Vyome, and acquire assets of metabolic health Biorad Medisys
ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, and Vyome Therapeutics,
Jul 10, 20246 min read
MedNews: Adult stem cell therapeutics developer BrainStorm Cell Therapeutics (Nasdaq: BCLI) raises $4 million
Autologous MSC-NTF cells have received Orphan Drug designation status from the FDA and the European Medicines Agency
Jul 6, 20243 min read
MedTalks - An interview with Brian Frenzel, CEO of TOSK discussing the company's business and its investment opportunities
TK-90 has completed “proof of concept” in Phase 2a clinical studies demonstrating safety and efficacy in head and neck cancer patients...
Jul 1, 20241 min read
MedNews: Holoclara closes $16 Million financing to advance worm-derived therapies for allergic and autoimmune disease
The company’s discovery engine builds on Dr. Choe’s research uncovering a unique pheromone language shared by roundworms
Jun 30, 20244 min read
MedNews: Ehealth Technologies partners with CancerX and the White House cancer moonshot to boost cancer innovation
Our patented technology with embedded AI collects and clinically organizes patient data, including records, lab results, images...
Jun 18, 20243 min read
MedNews: InduPro raises $85 Million to advance next-generation, proximity-based protein therapeutics for the treatment of cancer and autoimmune diseases
The financing will support the advancement of the first expected clinical product candidate targeting cancer tissue
Jun 14, 20245 min read
MedNews: Employee well being technology provider Navigate Wellbeing partners with content solution provider Caravan Wellness to benefit employees
This collaboration focuses on innovative workplace wellness programs, financial well-being education, mental and emotional health...
Jun 10, 20243 min read
MedNews: Immuno-pharma research and development company, AIM ImmunoTech raises $2 million from one investor
The Company’s lead product is a first-in-class investigational drug for cancers, viral diseases and disorders of the immune system
Jun 8, 20243 min read
MedNews: BMI OrganBank announces promising preclinical kidney transplant data for a novel medical device to reduce the wait-list for organ transplants
BMI OrganBank develops novel perfusion systems that can preserve and recondition organs and tissues.
Jun 6, 20243 min read
MedNews: Backpack Healthcare closes $14 million funding to revolutionize pediatric mental health care
the company offers an app and teletherapy services designed to provide accessible, inclusive, and comprehensive mental health support
May 11, 20244 min read
MedNews: Medical device company R3 Vascular announces $87 million financing
R3 Vascular will use the proceeds to support the ELITE FDA IDE trial of its bioresorbable scaffold, MAGNITUDE, for below-the-knee pad
May 10, 20245 min read
MedNews: Averto Medical debuts with $30 million financing to advance medical device that avoids the need for ostomy
oloSeal™ has the potential to help over 100,000 patients annually who undergo colorectal surgeries
May 9, 20243 min read
MedNews: Context Therapeutics (Nasdaq CNTX) raises $100 million in a private placement
Context Therapeutics Inc. (Nasdaq: CNTX) is a biopharmaceutical company advancing medicines for solid tumors.
May 6, 20243 min read
Vitestro raises €20 million for its autonomous blood draw device
With its autonomous blood draw technology Vitestro is transforming the blood draw industry globally.
May 1, 20244 min read
bottom of page